JP2023527153A5 - - Google Patents
Info
- Publication number
- JP2023527153A5 JP2023527153A5 JP2022570474A JP2022570474A JP2023527153A5 JP 2023527153 A5 JP2023527153 A5 JP 2023527153A5 JP 2022570474 A JP2022570474 A JP 2022570474A JP 2022570474 A JP2022570474 A JP 2022570474A JP 2023527153 A5 JP2023527153 A5 JP 2023527153A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063029361P | 2020-05-22 | 2020-05-22 | |
| US63/029,361 | 2020-05-22 | ||
| US202063030207P | 2020-05-26 | 2020-05-26 | |
| US63/030,207 | 2020-05-26 | ||
| US202063113116P | 2020-11-12 | 2020-11-12 | |
| US63/113,116 | 2020-11-12 | ||
| US202163146555P | 2021-02-05 | 2021-02-05 | |
| US63/146,555 | 2021-02-05 | ||
| PCT/US2021/033743 WO2021237143A1 (en) | 2020-05-22 | 2021-05-21 | Treatment of non-alcoholic steatohepatitis (nash) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023527153A JP2023527153A (ja) | 2023-06-27 |
| JP2023527153A5 true JP2023527153A5 (https=) | 2024-05-28 |
| JPWO2021237143A5 JPWO2021237143A5 (https=) | 2024-05-28 |
Family
ID=78707644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022570474A Pending JP2023527153A (ja) | 2020-05-22 | 2021-05-21 | 非アルコール性脂肪性肝炎（ｎａｓｈ）の処置 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230181601A1 (https=) |
| EP (1) | EP4153164A4 (https=) |
| JP (1) | JP2023527153A (https=) |
| KR (1) | KR20230015939A (https=) |
| CN (1) | CN115916181A (https=) |
| AU (1) | AU2021273936A1 (https=) |
| BR (1) | BR112022022737A2 (https=) |
| CA (1) | CA3195103A1 (https=) |
| MX (1) | MX2022014575A (https=) |
| TW (1) | TW202210081A (https=) |
| WO (1) | WO2021237143A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3494125B1 (en) | 2016-08-02 | 2022-06-22 | Virginia Commonwealth University | Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25hc3s) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI20848A (sl) * | 2001-03-14 | 2002-10-31 | Lek, Tovarna Farmacevtskih In Kemijskih Izdelkov, D.D. | Farmacevtska formulacija, ki vsebuje atorvastatin kalcij |
| US8399441B2 (en) * | 2004-10-25 | 2013-03-19 | Virginia Commonwealth University | Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis |
| WO2006047022A1 (en) * | 2004-10-25 | 2006-05-04 | Virginia Commonwealth University | Nuclear sulfated oxysterol, potent regulator of cholesterol homeostasis, for therapy of hypercholesterolemia, hyperlipidemia, and atherosclerosis |
| US9034859B2 (en) * | 2011-04-06 | 2015-05-19 | Virginia Commonwealth University | Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation |
| ES2869884T3 (es) * | 2011-09-16 | 2021-10-26 | Galectin Therapeutics Inc | Composiciones de galacto-ramnogalacturonato para el tratamiento de la esteatohepatitis no alcohólica y la enfermedad de hígado graso no alcohólico |
| SG11201507288UA (en) * | 2013-03-15 | 2015-10-29 | Mochida Pharm Co Ltd | Compositions and methods for treating non-alcoholic steatohepatitis |
| EP3494125B1 (en) * | 2016-08-02 | 2022-06-22 | Virginia Commonwealth University | Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25hc3s) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide |
| US20200222430A1 (en) * | 2016-08-02 | 2020-07-16 | Durect Corporation | Compositions comprising oxygenated cholesterol sulfate and at least one of polyalkylene glycol, carboxymethyl cellulose and polyoxylglyceride |
| CN110536682B (zh) * | 2017-04-18 | 2023-01-06 | 基恩菲特公司 | 依拉非诺或其衍生物与抗nash、抗纤维化或抗胆汁淤积药剂的组合 |
| KR102419458B1 (ko) * | 2017-10-06 | 2022-07-12 | 길리애드 사이언시즈, 인코포레이티드 | Acc 억제제를 포함하는 조합 요법 |
-
2021
- 2021-05-21 CN CN202180049351.XA patent/CN115916181A/zh active Pending
- 2021-05-21 TW TW110118457A patent/TW202210081A/zh unknown
- 2021-05-21 EP EP21808175.0A patent/EP4153164A4/en active Pending
- 2021-05-21 AU AU2021273936A patent/AU2021273936A1/en active Pending
- 2021-05-21 CA CA3195103A patent/CA3195103A1/en active Pending
- 2021-05-21 JP JP2022570474A patent/JP2023527153A/ja active Pending
- 2021-05-21 US US17/924,101 patent/US20230181601A1/en active Pending
- 2021-05-21 BR BR112022022737A patent/BR112022022737A2/pt not_active Application Discontinuation
- 2021-05-21 MX MX2022014575A patent/MX2022014575A/es unknown
- 2021-05-21 KR KR1020227043976A patent/KR20230015939A/ko active Pending
- 2021-05-21 WO PCT/US2021/033743 patent/WO2021237143A1/en not_active Ceased